42
Growth Score in past quarter
pts
Heat Score 42 in past quarter
-31 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3201286
Fustibal is a biotechnology startup that develops antibody-based nanomedicines for multi-targeted cancer therapy.
About the Company
Fustibal is a biotechnology startup that develops antibody-based nanomedicines for multi-targeted cancer therapy.
Its oncology therapeutics functionalize the tumor-targeting capability of antibodies with the large drug payload and the prolonged circulation time of nanomedicines for synergistic therapeutic effects. Through data-based computational
platforms and modular drug design, we repurpose and improve existing chemical and biological pharmaceuticals for efficacy, safety, and unmet medical needs.